Michael P. Clay

Intra- and interstrain differences in models of “behavioral despair”

Fengju Bai, Xia Li, Michael P. Clay et al. · Pharmacology Biochemistry and Behavior · 2001 · 245 citations

Social Sciences, Behavioral Sciences, Psychology +2

Antidepressant-like actions of an AMPA receptor potentiator (LY392098)

Xia Li, Joseph P. Tizzano, Kelly Griffey et al. · Neuropharmacology · 2001 · 224 citations

Medicine, Neuroscience, Pharmacology +12

Substituted 3-Imidazo[1,2-<i>a</i>]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino- [6,7,1-<i>hi</i>]indol-7-yl)pyrrole-2,5-diones as Highly Selective and Potent Inhibitors of Glycogen Synthase Kinase-3

Thomas A. Engler, James R. Henry, Sushant Malhotra et al. · Journal of Medicinal Chemistry · 2004 · 102 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Azetidinones as vasopressin V1a antagonists

Christophe Guillon, G. A. KOPPEL, Michael Brownstein et al. · Bioorganic & Medicinal Chemistry · 2006 · 73 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Dipeptides as Effective Prodrugs of the Unnatural Amino Acid (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740), a Selective Group II Metabotropic Glutamate Receptor Agonist

Ana B. Bueno, Iván Collado, Alfonso de Dios et al. · Journal of Medicinal Chemistry · 2005 · 65 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17